Natco Pharma Limited

NSE:NATCOPHARM India Drug Manufacturers - Specialty & Generic
Market Cap
$1.95 Billion
₹168.88 Billion INR
Market Cap Rank
#7720 Global
#293 in India
Share Price
₹942.90
Change (1 day)
-7.21%
52-Week Range
₹746.50 - ₹1039.20
All Time High
₹1591.09
About

NATCO Pharma Limited, a pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; a… Read more

Natco Pharma Limited (NATCOPHARM) - Total Liabilities

Latest total liabilities as of September 2025: ₹17.76 Billion INR

Based on the latest financial reports, Natco Pharma Limited (NATCOPHARM) has total liabilities worth ₹17.76 Billion INR as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Natco Pharma Limited - Total Liabilities Trend (2005–2025)

This chart illustrates how Natco Pharma Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Natco Pharma Limited Competitors by Total Liabilities

The table below lists competitors of Natco Pharma Limited ranked by their total liabilities.

Company Country Total Liabilities
SES Imagotag
LSE:0OA4
UK €1.55 Billion
U-Ming Marine Transport Corp
TW:2606
Taiwan NT$46.90 Billion
Jiangsu Changbao Steeltube Co Ltd
SHE:002478
China CN¥3.04 Billion
Zhejiang DunAn Artificial Environment Co Ltd
SHE:002011
China CN¥5.45 Billion
Longwell Co
TWO:6290
Taiwan NT$3.20 Billion
Limin Chemical Co Ltd
SHE:002734
China CN¥3.06 Billion
Hanwa Co., Ltd.
PINK:HNWAF
USA $732.75 Billion
YFY Inc
TW:1907
Taiwan NT$80.46 Billion

Liability Composition Analysis (2005–2025)

This chart breaks down Natco Pharma Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 4.10 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 1.58 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.21 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.17 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Natco Pharma Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Natco Pharma Limited (2005–2025)

The table below shows the annual total liabilities of Natco Pharma Limited from 2005 to 2025.

Year Total Liabilities Change
2025-03-31 ₹10.19 Billion -3.29%
2024-03-31 ₹10.53 Billion -130.26%
2023-03-31 ₹-34.80 Billion -511.59%
2022-03-31 ₹8.46 Billion +26.48%
2021-03-31 ₹6.68 Billion -16.76%
2020-03-31 ₹8.03 Billion -1.11%
2019-03-31 ₹8.12 Billion +27.07%
2018-03-31 ₹6.39 Billion -3.78%
2017-03-31 ₹6.64 Billion +27.59%
2016-03-31 ₹5.21 Billion -2.33%
2015-03-31 ₹5.33 Billion +15.12%
2014-03-31 ₹4.63 Billion -13.68%
2013-03-31 ₹5.36 Billion +24.53%
2012-03-31 ₹4.31 Billion +21.72%
2011-03-31 ₹3.54 Billion +47.28%
2010-03-31 ₹2.40 Billion -4.08%
2009-03-31 ₹2.50 Billion +28.90%
2008-03-31 ₹1.94 Billion +18.65%
2007-03-31 ₹1.64 Billion +6.27%
2006-03-31 ₹1.54 Billion -11.31%
2005-03-31 ₹1.74 Billion --